Release Date: 27/03/14 12:49 Summary: MTE: Supplementary Bidders Statement Price Sensitive: Yes Download Document 139.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%